Clinical Trials in Boston

Showing 1681-1700 of 8,503 trials

The COMPASSION Study

NCT06507930

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more

Dana-Farber Cancer Institute200 participantsStarted Sep 2024

Boston, Massachusetts, United States

RECRUITINGPhase 2< 1 mile

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

NCT06747858

ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.

Cystic FibrosisCFTR Gene Mutation

Arcturus Therapeutics, Inc.12 participantsStarted Dec 2024

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

NCT06729606

This study looks at the safety and effectiveness of Aviptadil in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Aviptadil plus current standard of care (SOC), or with placebo plus current SOC.

Covid19

National Institute of Allergy and Infectious Diseases (NIAID)471 participantsStarted Apr 2021

Tucson, Arizona, United States • Fresno, California, United States • Loma Linda, California, United States +37 more locations

The COMPASSION Study

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Find Trials by Condition in Boston

Osimertinib In EGFR Mutant Lung Cancer

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Improving Outcomes Assessment in Chronic GVHD

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

VItamin C in Thermal injuRY: The VICToRY Trial

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection